Replies to post #2899 on Synergy Pharmaceuticals Inc fka SGYPQ

[iandy]

The market for IBS-C is roughly 1/3 the size of CIC.

Here’s an interesting link comparing marketing in these indications:

http://blog.dtwresearch.com/?p=4027